Showing results (1221-1230 of 1,823) with videos related to

Sort By:
Pageof 183
Transplantation and Cellular Therapy|November 22, 2025
Increased Vascular Age in Patients with Fanconi Anemia after Hematopoietic Cell Transplantation: Results of a Single-Center Descriptive AnalysisMeera Srikanthan, Donald R Dengel, Nicholas G Evanoff, et al.
Transplantation and Cellular Therapy|November 24, 2025
Memory T Cell Donor Lymphocyte Infusion as a Treatment for Viral Infection After Pediatric Haploidentical Hematopoietic Stem Cell TransplantYixian Li, Yau Ki Wilson Chan, Pui Wah Pamela Lee, et al.
Transplantation and Cellular Therapy|December 1, 2025
Decitabine Conditioning Improves Natural Killer Cell Maturation and Limits CD8+ T Cell Terminal Differentiation Post-Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia PatientsJesper van Eck van der Sluijs, Diede van Ens, Ayla Grotens, et al.
Transplantation and Cellular Therapy|January 9, 2025
Everolimus with or without Mycophenolate Mofetil for Graft-versus-Host Disease Prophylaxis after Hematopoietic Stem Cell Transplantation in Children with Acute Kidney Injury: A Single-Center Retrospective AnalysisFelix Zirngibl, Pimrapat Gebert, Bianca Materne, et al.
Transplantation and Cellular Therapy|December 26, 2024
Early Engraftment and Immune Kinetics Following Allogeneic Transplant Using a Novel Reduced-Toxicity Transplant Strategy in Children/Adolescents with High-Risk Transfusion-Dependent Thalassemia: Early Results of the ThalFAbS TrialEnass H Raffa, Taylor M Harris, Chane Choed-Amphai, et al.
Transplantation and Cellular Therapy|December 19, 2024
Letermovir for Prevention of Recurrent Cytomegalovirus in High-Risk Allogeneic Hematopoietic Cell Transplantation RecipientsGyuri Han, Anat Stern, Yeon Joo Lee, et al.
Transplantation and Cellular Therapy|January 17, 2025
Impact of Obesity on GVHD in Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Hematologic MalignanciesValentina Ardila, Hong Li, Claudio Brunstein, et al.
Transplantation and Cellular Therapy|February 6, 2025
Bodyweight and Absolute Lymphocyte Count-Based Dosing of Rabbit Anti-thymocyte Globulin Results in Early CD4+ Immune Reconstitution in Patients with Inborn Errors of Metabolism Undergoing Umbilical Cord Blood TransplantationDaniel Drozdov, Jessica Kandil, Susie E Long, et al.
Transplantation and Cellular Therapy|February 9, 2025
American Society of Transplantation and Cellular Therapy Series: #8-Management and Prevention of Non-Aspergillus Molds in Hematopoietic Cell Transplantation RecipientsAbby P Douglas, Frederic Lamoth, Teny M John, et al.
Transplantation and Cellular Therapy|December 26, 2024
Pretransplant Chromosome Genomic Array Testing Improves Prognostication for Myelofibrosis Patients Undergoing TransplantationXiaoyu Qu, Emily Stevens, Matthew P Fitzgibbon, et al.
Pageof 183